Here, we present a combinatory approach with an EpCAM-directed bispecific antibody retargeting T cells via CD3 to tumor cells and EGFR-directed antibody-fusion proteins with costimulatory ligands of the B7 and TNF superfamily. This evidence concerns the gene EPCAM and neoplasm.